American Well Corporation Stock 12‑Month Price Target Raised to $11.58, Implies 11% Upside
Analyst estimates cited by FactSet show American Well Corp’s 12-month average price target increased from $8.50 to $11.58. The range is $7.50 to $16. Based on the Aug. 4 close, the target implies about 11% upside. The consensus rating remains “Hold” (1 Buy, 7 Hold, 0 Sell) across 8 analysts.
How this was made
The 30-second read
Why it matters
Consensus price target increased to $11.58, but the rating distribution stays mostly Hold (1 Buy, 7 Hold, 0 Sell), suggesting sentiment improvement without a clear re-rating to Buy.
Market read
Traders may use the PT increase as a sentiment input, but the lack of new company fundamentals limits trading edge.
What to watch
Without the underlying thesis for the PT change (earnings revisions, reimbursement updates, or product traction), traders may overestimate the signal content of the target raise.
Background
The piece summarizes FactSet-derived analyst consensus price targets and ratings for American Well.
Ticker impact
American Well’s average analyst price target rose from $8.50 to $11.58, implying about 11% upside versus the Aug. 4 close.
Mild positive bias for the stock over the next few sessions, with limited follow-through unless accompanied by new fundamentals beyond PT math.
The only new fact provided is the consensus target increase and unchanged Hold rating mix; no earnings, guidance, or operational catalyst is disclosed.
Market effects
Limited sector read-through because the article provides no new healthcare/telehealth operational or regulatory catalyst.
None indicated.
None indicated.
Counterpoint
A higher price target does not change the consensus stance, which remains Hold; the market may already price in analyst optimism and ignore PT-only updates.
Key entities
- companyAmerican Well Corporation
Subject of the article, with consensus analyst price target raised to $11.58 and Hold rating maintained.
